Heart preservation for transplantation: principles and strategies
- PMID: 10585116
- DOI: 10.1016/s0003-4975(99)01028-0
Heart preservation for transplantation: principles and strategies
Abstract
While transplantation is a proven modality for the treatment of end stage organ disease, an important determinant of outcome is the adequacy of organ preservation. Currently, heart preservation is limited to 4 to 6 hours of cold ischemic storage, and the effectiveness depends to a great extent on the solution and its temperature. The formulation of the solution is based on three basic principles: (a) hypothermic arrest of metabolism, (b) provision of a physical and biochemical environment to maintain viability of the structural components of the tissue during hypothermic metabolic slowing, and (c) minimization of reperfusion injury. This review presents the physiologic principles underlying the use of hypothermia and the chemical components of preservation fluids, specifically pertaining to preservation of the heart for transplantation. New approaches designed to protect the heart from surgical ischemic-reperfusion injury are presented as well. The object is to survey current strategies and generate insight into new and promising solutions designed to optimize donor heart preservation.
Similar articles
-
Long-term heart preservation by the combined method of simple immersion and coronary perfusion.J Heart Lung Transplant. 1996 Mar;15(3):269-74. J Heart Lung Transplant. 1996. PMID: 8777210
-
Donor heart preservation in an empty beating state under mild hypothermia.Ann Thorac Surg. 2010 May;89(5):1518-23. doi: 10.1016/j.athoracsur.2010.02.008. Ann Thorac Surg. 2010. PMID: 20417771
-
Endothelial damage during myocardial preservation and storage.Ann Thorac Surg. 2002 Feb;73(2):682-90. doi: 10.1016/s0003-4975(01)03029-6. Ann Thorac Surg. 2002. PMID: 11845908 Review.
-
Experimental evaluation of Celsior, a new heart preservation solution.Eur J Cardiothorac Surg. 1994;8(4):207-13. doi: 10.1016/1010-7940(94)90117-1. Eur J Cardiothorac Surg. 1994. PMID: 8031565
-
Preservation of the donor heart: from basic science to clinical studies.Interact Cardiovasc Thorac Surg. 2015 Apr;20(4):510-9. doi: 10.1093/icvts/ivu432. Epub 2014 Dec 23. Interact Cardiovasc Thorac Surg. 2015. PMID: 25538253 Review.
Cited by
-
The Critical Role of Bioenergetics in Donor Cardiac Allograft Preservation.J Cardiovasc Transl Res. 2016 Jun;9(3):176-183. doi: 10.1007/s12265-016-9692-2. Epub 2016 May 10. J Cardiovasc Transl Res. 2016. PMID: 27164961 Review.
-
Is there any cardioprotective role of Taurine during cold ischemic period following global myocardial ischemia?J Cardiothorac Surg. 2011 Mar 18;6:31. doi: 10.1186/1749-8090-6-31. J Cardiothorac Surg. 2011. PMID: 21418563 Free PMC article.
-
Effects of luteolin on regulatory proteins and enzymes for myocyte calcium circulation in hypothermic preserved rat heart.Exp Ther Med. 2018 Feb;15(2):1433-1441. doi: 10.3892/etm.2017.5514. Epub 2017 Nov 16. Exp Ther Med. 2018. PMID: 29399124 Free PMC article.
-
Comparison of HTK-Custodiol and St-Thomas solution as cardiac preservation solutions on early and midterm outcomes following heart transplantation.Interdiscip Cardiovasc Thorac Surg. 2024 Jun 5;38(6):ivae093. doi: 10.1093/icvts/ivae093. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 38806181 Free PMC article.
-
Protective Effect of Creatine Elevation against Ischaemia Reperfusion Injury Is Retained in the Presence of Co-Morbidities and during Cardioplegia.PLoS One. 2016 Jan 14;11(1):e0146429. doi: 10.1371/journal.pone.0146429. eCollection 2016. PLoS One. 2016. PMID: 26765737 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical